ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

During the Trading Day
20.55 +0.41 / +2.04%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
20.55 0.00 / 0.00%
 
Volume: 8.0K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.0B

Company Description

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is developing a portfolio consisting of four advanced product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis. It also has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma. ACADIA Pharmaceuticals was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Contact Information

ACADIA Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego California 92121-1402
P:(858) 558-2871
Investor Relations:

Employees

Shareholders

Other institutional45.71%
Mutual fund holders40.46%
Individual stakeholders30.43%

Top Executives

Uli HacksellPresident, CEO, CFO, Director & CAO
Roger M. MillsChief Medical Officer
Terrence O. MooreChief Commercial Officer & Executive VP
Glenn F. BaitySecretary, Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.